Werewolf Therapeutics, Inc. (HOWL)
HOWL Stock Price Chart
Explore Werewolf Therapeutics, Inc. interactive price chart. Choose custom timeframes to analyze HOWL price movements and trends.
HOWL Company Profile
Discover essential business fundamentals and corporate details for Werewolf Therapeutics, Inc. (HOWL) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
30 Apr 2021
Employees
46.00
Website
https://werewolftx.comCEO
Daniel J. Hicklin
Description
Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the treatment of cancer. The company, through its proprietary PREDATOR platform, designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional proinflammatory immune therapies. Its lead product candidates are WTX-124, a conditionally activated Interleukin-2 INDUKINE molecule for the treatment of advanced solid tumors; and WTX-330, a conditionally activated Interleukin-12 INDUKINE molecule for the treatment of relapsed or refractory advanced or metastatic solid tumors or lymphoma. The company is also developing WTX-613, a conditionally activated interferon alpha INDUKINE molecule for the treatment of solid tumors and hematologic malignancies. Werewolf Therapeutics, Inc. was incorporated in 2017 and is headquartered in Cambridge, Massachusetts.
HOWL Financial Timeline
Browse a chronological timeline of Werewolf Therapeutics, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 6 Nov 2025
EPS estimate is -$0.39.
Earnings released on 14 Aug 2025
EPS came in at -$0.40 surpassing the estimated -$0.50 by +20.00%.
Earnings released on 8 May 2025
EPS came in at -$0.40 surpassing the estimated -$0.44 by +9.09%.
Earnings released on 11 Mar 2025
EPS came in at -$0.46 falling short of the estimated -$0.43 by -6.98%.
Earnings released on 7 Nov 2024
EPS came in at -$0.38 surpassing the estimated -$0.41 by +7.32%.
Earnings released on 8 Aug 2024
EPS came in at -$0.43 falling short of the estimated -$0.38 by -13.16%, while revenue for the quarter reached $1.14M , beating expectations by +35.78%.
Earnings released on 3 May 2024
EPS came in at -$0.39 falling short of the estimated -$0.35 by -11.43%, while revenue for the quarter reached $742.00K , missing expectations by -49.09%.
Earnings released on 7 Mar 2024
EPS came in at -$0.33 surpassing the estimated -$0.43 by +23.26%, while revenue for the quarter reached $1.50M , missing expectations by -22.78%.
Earnings released on 14 Nov 2023
EPS came in at -$0.23 surpassing the estimated -$0.27 by +14.81%, while revenue for the quarter reached $5.90M , beating expectations by +270.65%.
Earnings released on 10 Aug 2023
EPS came in at -$0.14 surpassing the estimated -$0.41 by +65.85%, while revenue for the quarter reached $8.08M , beating expectations by +156.54%.
Earnings released on 11 May 2023
EPS came in at -$0.34 surpassing the estimated -$0.49 by +30.61%, while revenue for the quarter reached $4.46M , beating expectations by +119.54%.
Earnings released on 23 Mar 2023
EPS came in at -$0.39 surpassing the estimated -$0.59 by +33.90%, while revenue for the quarter reached $7.28M , beating expectations by +251.50%.
Earnings released on 10 Nov 2022
EPS came in at -$0.40 surpassing the estimated -$0.60 by +33.33%, while revenue for the quarter reached $4.97M , beating expectations by +62.95%.
Earnings released on 11 Aug 2022
EPS came in at -$0.53 falling short of the estimated -$0.30 by -76.67%, while revenue for the quarter reached $4.15M , missing expectations by -17.04%.
Earnings released on 10 May 2022
EPS came in at -$0.56 surpassing the estimated -$0.60 by +6.67%.
Earnings released on 24 Mar 2022
EPS came in at -$0.66 falling short of the estimated -$0.56 by -17.86%.
Earnings released on 10 Nov 2021
EPS came in at -$0.51 falling short of the estimated -$0.45 by -13.33%.
Earnings released on 12 Aug 2021
EPS came in at -$3.82 falling short of the estimated -$0.28 by -1.26K%.
Earnings released on 10 Jun 2021
EPS came in at -$83.36 falling short of the estimated -$0.46 by -18.02K%.
Earnings released on 30 Apr 2021
EPS came in at -$0.83 .
Earnings released on 30 Sept 2020
EPS came in at -$0.68 .
HOWL Stock Performance
Access detailed HOWL performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.